LeafNLP Demos
Back to explore

Report #2885811

Received Feb 17, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
51 yrs
State
NH
Recovered
Unknown
Vaccinated
Feb 13, 2026
Onset
Feb 13, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2ND549—

Symptoms (2)

Incorrect dose administeredProduct leakage

Symptom narrative

there was a leakage; Underdose; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete dose administered in a adult male patient who received Herpes zoster (Shingrix) (batch number ND549, expiry date 10-JUN-2027) for prophylaxis. On 13-FEB-2026, the patient received the 2nd dose of Shingrix. On 13-FEB-2026, an unknown time after receiving Shingrix, the patient experienced incomplete dose administered (Verbatim: Underdose). On an unknown date, the patient experienced product leakage (Verbatim: there was a leakage). The outcome of the incomplete dose administered and product leakage were not applicable. Additional Information: GSK Receipt Date: 13-FEB-2026 The reporter reported that after she administered a dose of Shingrix to a male patient and some of the medication was not administered, there was a leakage. The reported asked what the recommendations or patient needed to be revaccinated. The batch number was not provided upon follow- up with the reporter.